CD4 and squamous cell intraepithelial neoplasia: A 2003 paper from HERS cohort reported that being on HAART was not an independent predictor of progression of SIL, although poorer immune status (reflected by CD4+ cell counts <200/mm3) was associated with significantly higher odds of progression[25].